Besides, as therapeutic manipulation of ADP‐ribosylation has been reported to positively affect several metabolic disorders,23, 42 the findings on the polymorphism of the MACROD2 gene encoding the ADP‐ribosylhydrolase of our study could be the basis for discovering candidate targets for the management and treatment of metabolic disease. The gene discussed is MACROD2; the disease is Other metabolic disease.